# Coya Therapeutics, Inc.: filings

COYA · Nasdaq · CIK 1835022 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coya.md) · [Financials](/companies/coya/financials.md) · [Filings](/companies/coya/filings.md) · [Insiders](/companies/coya/insiders.md)

## Reports and events: 79 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 54, 8-K 54, 3 13, 10-Q 11, CORRESP 10, UPLOAD 10, EFFECT 7, SC 13G/A 6, DEFA14A 5, S-3 5, SCHEDULE 13G/A 5, 10-K 4, 424B3 4, ARS 4, D 4, DEF 14A 4, 424B5 3, SC 13G 3, 10-K/A 2, 424B4 2, DRS/A 2, DRSLTR 2, S-1/A 2, S-8 2, SEC STAFF LETTER 2, 424B7 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, FWP 1, POS AM 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 12:30 ET | [8-K](/filings/0001193125-26-421066.md) | 8.01 Other events | 0001193125-26-421066 |
| 2026-10-05 | 12:30 ET | [8-K](/filings/0001193125-26-413218.md) | 8.01 Other events | 0001193125-26-413218 |
| 2026-09-15 | 12:15 ET | [8-K](/filings/0001193125-26-391378.md) | 8.01 Other events | 0001193125-26-391378 |
| 2026-08-11 | 12:06 ET | [10-Q](/filings/0001193125-26-343481.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343481 |
| 2026-08-11 | 12:03 ET | [8-K](/filings/0001193125-26-343473.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343473 |
| 2026-08-07 | 21:00 ET | [8-K/A](/filings/0001193125-26-340449.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-340449 |
| 2026-06-25 | 21:00 ET | [8-K](/filings/0001193125-26-282989.md) | 5.07 Shareholder vote results | 0001193125-26-282989 |
| 2026-05-13 | 12:30 ET | [DEF 14A](/filings/0001193125-26-220688.md) | Proxy statement, period 2026-06-25 | 0001193125-26-220688 |
| 2026-05-12 | 12:48 ET | [8-K](/filings/0001193125-26-218282.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-218282 |
| 2026-05-12 | 11:41 ET | [10-Q](/filings/0001193125-26-218201.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218201 |
| 2026-05-12 | 11:39 ET | [8-K](/filings/0001193125-26-218198.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-218198 |
| 2026-04-02 | 12:48 ET | [8-K](/filings/0001193125-26-139094.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-139094 |
| 2026-03-16 | 12:11 ET | [10-K](/filings/0001193125-26-107281.md) | Annual report, period 2025-12-31 | 0001193125-26-107281 |
| 2026-03-16 | 12:07 ET | [8-K](/filings/0001193125-26-107276.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107276 |
| 2026-01-30 | 13:06 ET | [8-K](/filings/0001193125-26-030531.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-030531 |
| 2026-01-20 | 13:20 ET | [8-K](/filings/0001193125-26-016017.md) | 8.01 Other events | 0001193125-26-016017 |
| 2026-01-08 | 13:10 ET | [8-K](/filings/0001193125-26-007042.md) | 8.01 Other events | 0001193125-26-007042 |
| 2025-12-17 | 13:00 ET | [8-K](/filings/0001193125-25-321737.md) | 8.01 Other events | 0001193125-25-321737 |
| 2025-11-12 | 13:13 ET | [10-Q](/filings/0001193125-25-276058.md) | Quarterly report, period 2025-09-30 | 0001193125-25-276058 |
| 2025-11-12 | 13:03 ET | [8-K](/filings/0001193125-25-276022.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-276022 |
| 2025-10-27 | 11:36 ET | [8-K](/filings/0001193125-25-250709.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-250709 |
| 2025-09-02 | 12:30 ET | [8-K](/filings/0001193125-25-193450.md) | 8.01 Other events | 0001193125-25-193450 |
| 2025-08-12 | 12:08 ET | [10-Q](/filings/0000950170-25-106934.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106934 |
| 2025-08-12 | 12:06 ET | [8-K](/filings/0000950170-25-106932.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106932 |
| 2025-07-29 | 21:10 ET | [8-K](/filings/0001193125-25-168115.md) | 8.01 Other events | 0001193125-25-168115 |
| 2025-07-01 | 12:00 ET | [8-K](/filings/0001193125-25-153465.md) | 8.01 Other events | 0001193125-25-153465 |
| 2025-06-26 | 21:00 ET | [8-K](/filings/0001193125-25-149104.md) | 5.07 Shareholder vote results | 0001193125-25-149104 |
| 2025-05-16 | 21:01 ET | [DEF 14A](/filings/0001193125-25-121779.md) | Proxy statement, period 2025-06-26 | 0001193125-25-121779 |
| 2025-05-13 | 12:14 ET | [10-Q](/filings/0000950170-25-069824.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069824 |
| 2025-05-13 | 12:07 ET | [8-K](/filings/0000950170-25-069819.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-069819 |
| 2025-04-28 | 21:07 ET | [10-K/A](/filings/0001193125-25-100816.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-100816 |
| 2025-03-18 | 12:26 ET | [10-K](/filings/0000950170-25-040782.md) | Annual report, period 2024-12-31 | 0000950170-25-040782 |
| 2025-03-18 | 12:20 ET | [8-K](/filings/0000950170-25-040779.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040779 |
| 2024-11-06 | 13:06 ET | [10-Q](/filings/0000950170-24-121837.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121837 |
| 2024-11-06 | 13:02 ET | [8-K](/filings/0000950170-24-121833.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-121833 |
| 2024-11-05 | 22:02 ET | [8-K](/filings/0001193125-24-251319.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-251319 |
| 2024-10-31 | 20:42 ET | [8-K](/filings/0001193125-24-248755.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-248755 |
| 2024-10-29 | 12:00 ET | [8-K](/filings/0001193125-24-246171.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-246171 |
| 2024-10-22 | 13:08 ET | [8-K](/filings/0001193125-24-240775.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-240775 |
| 2024-08-19 | 13:10 ET | [8-K](/filings/0001193125-24-202551.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-202551 |
| 2024-08-12 | 12:13 ET | [10-Q](/filings/0000950170-24-095075.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095075 |
| 2024-08-12 | 12:04 ET | [8-K](/filings/0000950170-24-095072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-095072 |
| 2024-07-15 | 10:10 ET | [8-K](/filings/0001193125-24-178809.md) | 8.01 Other events | 0001193125-24-178809 |
| 2024-06-05 | 12:00 ET | [8-K](/filings/0001193125-24-154729.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-154729 |
| 2024-05-20 | 21:00 ET | [8-K](/filings/0001193125-24-142950.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-142950 |
| 2024-05-09 | 20:26 ET | [10-Q](/filings/0000950170-24-057056.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057056 |
| 2024-05-09 | 20:20 ET | [8-K](/filings/0000950170-24-057018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-057018 |
| 2024-05-08 | 21:21 ET | [8-K](/filings/0001193125-24-134376.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-134376 |
| 2024-03-28 | 20:30 ET | [DEF 14A](/filings/0000950170-24-038090.md) | Proxy statement, period 2024-05-08 | 0000950170-24-038090 |
| 2024-03-19 | 12:27 ET | [10-K](/filings/0000950170-24-033161.md) | Annual report, period 2023-12-31 | 0000950170-24-033161 |

Page 1 of 2. [Older](/companies/coya/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.